Hepatitis C and Human Immunodeficiency Virus Kidney Transplantation: The Mount Sinai Experience.

Hepatitis C and Human Immunodeficiency Virus Kidney Transplantation: The Mount Sinai Experience. Clin Transpl. 2015;31:69-78 Authors: Nair V, Khaim R, El-Salem F, Kent R, Lerner S, Berger A, Miko L, Rollins B, Ebcioglu Z, Delaney V, Sehgal V, Menon M, Ames S, Benvenisty A, Wadhera V, Arvelakas A, Schiano T, Rana M, Huprikar S, Florman S, Shapiro R Abstract Mount Sinai Hospital in New York has a long history in the field of organ transplantation. The first kidney transplant at Mount Sinai was performed in 1967 by the late Dr. Lewis Burrows and the first laparoscopic donor nephrectomy in New York was performed at Mount Sinai in 1996. Over 3000 kidney transplantations have been performed at Mount Sinai. In the early 1990s, the first hepatitis C virus (HCV) positive patient at Mount Sinai underwent a kidney transplant and the first kidney transplant in a patient with human immunodeficiency virus (HIV) in New York was performed at Mount Sinai in 2001. In general, these patients have done well after renal transplantation, with outcomes similar to those seen in non-infected patients. This chapter will describe the evolution of immunosuppressive regimens in HCV positive and HIV positive patients, and will describe the outcomes of kidney transplantation in these patients. Given the favorable outcomes, it is reasonable to continue to offer renal transplantation as a treatment for end stage renal disease patients with HCV and/or HIV. PM...
Source: Clinical Transplants - Category: Transplant Surgery Tags: Clin Transpl Source Type: research